SCHEMBL2724167

SCHEMBL2724167

C=C(C)Cc1cc(C)cc(-n2nc3ccc(OC)cc3n2)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.41
RAB9A P51151 9/20 0.41
POLB P06746 2/20 0.38
LMNA P02545 2/20 0.36
KDM4E B2RXH2 7/20 0.34
ALDH1A1 P00352 5/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
MAPT P10636 4/20 0.34
GAA P10253 1/20 0.34
TP53 P04637 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MEN1 O00255 1/20 0.33
CASP3 P42574 1/20 0.33
KMT2A Q03164 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 4/20 0.32
HSD17B10 Q99714 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394296 0.84 NPC1 (0.58) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL285622 0.84 NPC1 (0.58) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL29814388 0.80 NPC1 (0.49) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL352438 0.80 NPC1 (0.49) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL1098570 0.76 ALDH1A1 (0.43) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL2725437 0.75 NPC1 (0.36) NPC1RAB9APOLBLMNAKDM4E
Benzotriazole SCHEMBL20580212 0.74 NPC1 (0.46) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL1101121 0.74 ALDH1A1 (0.36) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL6941182 0.74 RAB9A (0.66) NPC1RAB9APOLBLMNAKDM4E
SCHEMBL22549010 0.73 NPC1 (0.36) NPC1RAB9APOLBLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206204-B2 Process for preparing 2-hydroxyphenyl benzotriazole siloxane compounds L'OREAL (FR) 2015-12-08 US claimed
EP-2632905-B1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS ORÉAL L (FR) 2015-05-27 EP claimed
EP-2632905-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'Oréal (FR) 2013-09-04 EP claimed
US-20130204006-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2013-08-08 US claimed
WO-2012055064-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2012-05-03 WO claimed
US-9447123-B2 Process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds; use of the said compounds obtained via the process in the synthesis of siloxane compounds containing a 2-hydroxyphenylbenzotriazole function L'OREAL (FR) 2016-09-20 US disclosed
US-9447123-B2 Process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds; use of the said compounds obtained via the process in the synthesis of siloxane compounds containing a 2-hydroxyphenylbenzotriazole function L'OREAL (FR) 2016-09-20 US disclosed
US-9447123-B2 Process for preparing 2-hydroxyphenyl alkenyl benzotriazole compounds; use of the said compounds obtained via the process in the synthesis of siloxane compounds containing a 2-hydroxyphenylbenzotriazole function L'OREAL (FR) 2016-09-20 US disclosed
EP-2632904-B1 PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION ORÉAL L (FR) 2016-03-23 EP disclosed
EP-2632904-B1 PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION ORÉAL L (FR) 2016-03-23 EP disclosed
US-9206204-B2 Process for preparing 2-hydroxyphenyl benzotriazole siloxane compounds L'OREAL (FR) 2015-12-08 US disclosed
US-9206204-B2 Process for preparing 2-hydroxyphenyl benzotriazole siloxane compounds L'OREAL (FR) 2015-12-08 US disclosed
EP-2632905-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'Oréal (FR) 2013-09-04 EP disclosed
US-20130204006-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2013-08-08 US disclosed
US-20130204006-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2013-08-08 US disclosed
US-20130204006-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2013-08-08 US disclosed
WO-2012055064-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012055064-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012055063-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012055063-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL ALKENYL BENZOTRIAZOLE COMPOUNDS AND PROCESS FOR PREPARING SILOXANE COMPOUNDS CONTAINING 2-HYDROXYPHENYL BENZOTRIZOLE FUNCTION L'OREAL (FR) 2012-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130204006-A1 PROCESS FOR PREPARING 2-HYDROXYPHENYL BENZOTRIAZOLE SILOXANE COMPOUNDS HRH3, PAH, HRH4 NPC1 3800/4885RAB9A 4199/4885POLB 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.